Minerva IPO Presentation Deck
Minerva ES Clinical Trials Overview
Minerva Single Arm Study
Endpoint
Study
patients
ese
Reduction in blood loss
assessed by Pictorial Blood
Loss Assessment Chart
(PBLAC)¹
110 patients
• Enrolled across seven centers in
Canada, Hungary, and Mexico
Minerva Randomized Controlled Trial
Reduction in blood loss assessed by
Alkaline Hematin (AH) Method²
153 patients
• Randomized 2:1
• Enrolled across 13 centers in the United
States, Canada, and Mexico
*Pictorial Blood Loss Assessment Chart (PBLAC) is a time-tested and validated menstrual diary scoring system developed by Higham. Patient success is defined as a reduction in PBLAC score from > 150
pre-treatment to a PBLAC score of ≤ 75 without incidence of acute treatment failure or additional therapy
2 Alkaline Hematin (AH) method is a validated, quantitative process of measuring blood loss by assessing used sanitary products. Patient success is defined as a reduction in AH value 2 160ml to AH value s
80ml without incidence of acute treatment failure or additional therapy
18View entire presentation